MCH−/− Mice Are Resistant to Aging-Associated Increases in Body Weight and Insulin Resistance

Diabetes - Tập 55 Số 2 - Trang 428-434 - 2006
Justin Y. Jeon1,2,3,4, Richard L. Bradley1,3,4, Efi Kokkotou1,3,5, Francis E. Marino3,4, Xiaomei Wang3, Pavlos Pissios1,3,4, Eleftheria Maratos–Flier1,3,4
1Department of Medicine, Harvard Medical School, Boston, Massachusetts
2Department of Sport and Leisure Studies, Yonsei University, Seoul, Korea
3Division of Endocrinology, Department of Medicine, Beth Israel Medical Center, Boston, Massachusetts
4Research Division, Joslin Diabetes Center, Boston, Massachusetts.
5Division of Gastroenterology, Department of Medicine, Beth Israel Medical Center, Boston, Massachusetts

Tóm tắt

Ablation of the hypothalamic peptide, melanin-concentrating hormone (MCH), leads to a lean phenotype and resistance to diet-induced obesity. Observation of MCH−/− mice at older ages suggested that these effects persist in mice >1 year old. Leanness secondary to caloric restriction is known to be associated with improved glucose tolerance as well as an overall increase in life span. Because the MCH−/− model represents leanness secondary to increased energy expenditure rather than caloric restriction, we were interested in determining whether this model of leanness would be associated with beneficial metabolic effects at older ages. To assess the effects of MCH ablation over a more prolonged period, we monitored male and female MCH−/− mice up to 19 months. The lean phenotype of MCH−/− mice persisted over the duration of the study. At 19 months, MCH−/− male and female mice weighed 23.4 and 30.8% less than their wild-type counterparts, a result of reduced fat mass in MCH−/− mice. Aged MCH−/− mice exhibited better glucose tolerance and were more insulin sensitive compared with wild-type controls. Aging-associated decreases in locomotor activity were also attenuated in MCH−/− mice. We also evaluated two molecules implicated in the pathophysiology of aging, p53 and silent inflammatory regulator 2 (Sir2). We found that expression of the tumor suppressor protein p53 was higher in MCH−/− mice at 9 and 19 months of age. In contrast, expression of Sir2 was unchanged. In aggregate, these findings suggest that MCH ablation improves the long-term outcome for several indicators of the aging process.

Từ khóa


Tài liệu tham khảo

Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP: The continuing epidemics of obesity and diabetes in the United States. JAMA 286:1195–1200,2001

You T, Yang R, Lyles MF, Gong D, Nicklas BJ: Abdominal adipose tissue cytokine gene expression: relationship to obesity and metabolic risk factors. Am J Physiol Endocrinol Metab,2005 288:E741–E747

Barbieri M, Rizzo MR, Manzella D, Paolisso G: Age-related insulin resistance: is it an obligatory finding? The lesson from healthy centenarians. Diabetes Metab Res Rev 17:19–26,2001

Barzilai N, Banerjee S, Hawkins M, Chen W, Rossetti L: Caloric restriction reverses hepatic insulin resistance in aging rats by decreasing visceral fat. J Clin Invest 101:1353–1361,1998

Barzilai N, She L, Liu BQ, Vuguin P, Cohen P, Wang J, Rossetti L: Surgical removal of visceral fat reverses hepatic insulin resistance. Diabetes 48:94–98,1999

Shimada M, Tritos NA, Lowell BB, Flier JS, Maratos-Flier E: Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature 396:670–674,1998

Flier JS: Obesity wars: molecular progress confronts an expanding epidemic. Cell 116:337–350,2004

Um SH, Frigerio F, Watanabe M, Picard F, Joaquin M, Sticker M, Fumagalli S, Allegrini PR, Kozma SC, Auwerx J, Thomas G: Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 431:200–205,2004

Pissios P, Maratos-Flier E: Melanin-concentrating hormone: from fish skin to skinny mammals. Trends Endocrinol Metab 14:243–248,2003

Borowsky B, Durkin MM, Ogozalek K, Marzabadi MR, DeLeon J, Lagu B, Heurich R, Lichtblau H, Shaposhnik Z, Daniewska I, Blackburn TP, Branchek TA, Gerald C, Vaysse PJ, Forray C: Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist. Nat Med 8:825–830,2002

Clegg DJ, Air EL, Benoit SC, Sakai RS, Seeley RJ, Woods SC: Intraventricular melanin-concentrating hormone stimulates water intake independent of food intake. Am J Physiol Regul Integr Comp Physiol 284:R494–R499,2003

Gomori A, Ishihara A, Ito M, Mashiko S, Matsushita H, Yumoto M, Tanaka T, Tokita S, Moriya M, Iwaasa H, Kanatani A: Chronic intracerebroventricular infusion of MCH causes obesity in mice: melanin-concentrating hormone. Am J Physiol Endocrinol Metab 284:E583–E588,2003

Ito M, Gomori A, Ishihara A, Oda Z, Mashiko S, Matsushita H, Yumoto M, Sano H, Tokita S, Moriya M, Iwaasa H, Kanatani A: Characterization of MCH-mediated obesity in mice. Am J Physiol Endocrinol Metab 284:E940–E945,2003

Ludwig DS, Mountjoy KG, Tatro JB, Gillette JA, Frederich RC, Flier JS, Maratos-Flier E: Melanin-concentrating hormone: a functional melanocortin antagonist in the hypothalamus. Am J Physiol 274:E627–E633,1998

Marsh DJ, Weingarth DT, Novi DE, Chen HY, Trumbauer ME, Chen AS, Guan XM, Jiang MM, Feng Y, Camacho RE, Shen Z, Frazier EG, Yu H, Metzger JM, Kuca SJ, Shearman LP, Gopal-Truter S, MacNeil DJ, Strack AM, MacIntyre DE, Van der Ploeg LH, Qian S: Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism. Proc Natl Acad Sci U S A 99:3240–3245,2002

Segal-Lieberman G, Bradley RL, Kokkotou E, Carlson M, Trombly DJ, Wang X, Bates S, Myers MG Jr, Flier JS, Maratos-Flier E: Melanin-concentrating hormone is a critical mediator of the leptin-deficient phenotype. Proc Natl Acad Sci U S A 100:10085–10090,2003

Pissios P, Trombly DJ, Tzameli I, Maratos-Flier E: Melanin-concentrating hormone receptor 1 activates extracellular signal-regulated kinase and synergizes with G(s)-coupled pathways. Endocrinology 144:3514–3523,2003

Cohen HY, Miller C, Bitterman KJ, Wall NR, Hekking B, Kessler B, Howitz KT, Gorospe M, de Cabo R, Sinclair DA: Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 305:390–392,2004

Lin SJ, Ford E, Haigis M, Liszt G, Guarente L: Calorie restriction extends yeast life span by lowering the level of NADH. Genes Dev 18:12–16,2004

Ryan KM, Phillips AC, Vousden KH: Regulation and function of the p53 tumor suppressor protein. Curr Opin Cell Biol 13:332–337,2001

Vogelstein B, Lane D, Levine AJ: Surfing the p53 network. Nature 408:307–310,2000

Tyner SD, Venkatachalam S, Choi J, Jones S, Ghebranious N, Igelmann H, Lu X, Soron G, Cooper B, Brayton C, Hee Park S, Thompson T, Karsenty G, Bradley A, Donehower LA: p53 mutant mice that display early ageing-associated phenotypes. Nature 415:45–53,2002

Dumble M, Gatza C, Tyner S, Venkatachalam S, Donehower LA: Insights into aging obtained from p53 mutant mouse models. Ann N Y Acad Sci 1019:171–177,2004

Campisi J: Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120:513–522,2005

Giese H, Snyder WK, van Oostrom C, van Steeg H, Dolle ME, Vijg J: Age-related mutation accumulation at a lacZ reporter locus in normal and tumor tissues of Trp53-deficient mice. Mutat Res 514:153–163,2002

Lin SJ, Defossez PA, Guarente L: Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science 289:2126–2128,2000

Rogina B, Helfand SL: Sir2 mediates longevity in the fly through a pathway related to calorie restriction. Proc Natl Acad Sci U S A 101:15998–16003,2004

Guarente L, Picard F: Calorie restriction: the SIR2 connection. Cell 120:473–482,2005

Bellizzi D, Rose G, Cavalcante P, Covello G, Dato S, De Rango F, Greco V, Maggiolini M, Feraco E, Mari V, Franceschi C, Passarino G, De Benedictis G: A novel VNTR enhancer within the SIRT3 gene, a human homologue of SIR2, is associated with survival at oldest ages. Genomics 85:258–263,2005

Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, Pandita TK, Guarente L, Weinberg RA: hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107:149–159,2001

Smith J: Human Sir2 and the “silencing ” of p53 activity. Trends Cell Biol 12:404–406,2002

Kokkotou E, Jeon JY, Wang X, Marino FE, Carlson M, Trombly DJ, Maratos-Flier E: Mice with MCH ablation resist diet-induced obesity through strain-specific mechanisms. Am J Physiol Regul Integr Comp Physiol 289:R117–R124,2005

Astrand A, Bohlooly YM, Larsdotter S, Mahlapuu M, Andersen H, Tornell J, Ohlsson C, Snaith M, Morgan DG: Mice lacking melanin-concentrating hormone receptor 1 demonstrate increased heart rate associated with altered autonomic activity. Am J Physiol Regul Integr Comp Physiol 287:R749–R758,2004

Barzilai N, Rossetti L: Age-related changes in body composition are associated with hepatic insulin resistance in conscious rats. Am J Physiol 270:E930–E936,1996

Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS: A transgenic model of visceral obesity and the metabolic syndrome. Science 294:2166–2170,2001

Hotamisligil GS: The role of TNFalpha and TNF receptors in obesity and insulin resistance. J Intern Med 245:621–625,1999

Wang C, Weindruch R, Fernandez JR, Coffey CS, Patel P, Allison DB: Caloric restriction and body weight independently affect longevity in Wistar rats. Int J Obes Relat Metab Disord 28:357–362,2004

Caloric restriction and longevity. Harv Mens Health Watch 2:6–7,1998

Das M, Gabriely I, Barzilai N: Caloric restriction, body fat and ageing in experimental models. Obes Rev 5:13–19,2004

Berrigan D, Perkins SN, Haines DC, Hursting SD: Adult-onset calorie restriction and fasting delay spontaneous tumorigenesis in p53-deficient mice. Carcinogenesis 23:817–822,2002

Patel AC, Nunez NP, Perkins SN, Barrett JC, Hursting SD: Effects of energy balance on cancer in genetically altered mice. J Nutr 134:3394S–3398S,2004

Lamming DW, Wood JG, Sinclair DA: Small molecules that regulate lifespan: evidence for xenohormesis. Mol Microbiol 53:1003–1009,2004

DePinho RA: The age of cancer. Nature 408:248–254,2000

Xiao ZQ, Yu Y, Khan A, Jaszewski R, Ehrinpreis MN, Majumdar AP: Induction of G(1) checkpoint in the gastric mucosa of aged rats. Am J Physiol 277:G929–G934,1999

Xiao ZQ, Jaszewski R, Majumdar AP: Aging enhances G(1) phase in the colonic mucosa of rats. Mech Ageing Dev 116:1–14,2000

Nitahara JA, Cheng W, Liu Y, Li B, Leri A, Li P, Mogul D, Gambert SR, Kajstura J, Anversa P: Intracellular calcium, DNase activity and myocyte apoptosis in aging Fischer 344 rats. J Mol Cell Cardiol 30:519–535,1998